#std's

The US is dealing with an "out-of-control" epidemic of sexually transmitted infections, according to the National Coalition of STD Directors. The warning, issued in January, followed the release of an annual data report on STIs by the US Centers for Disease Control and Prevention (CDC). The exasperation of public health officials can be felt in the very first sentence of the online announcement. "Yet again," the CDC website said, "more than 2.5 million cases of chlamydia, gonorrhea, and syphilis were reported in the United States."

[Chancroid, Chlamydia, Crabs, Gonorrhea, Hepatitis, Herpes, HIV/AIDS, Human Papillomavirus, Lymphogranuloma Venereum, Molluscum Contagiosum, Nongonococcal Urethritis, Pelvic Inflammatory Disease, Scabies, Syphilis, Trichomoniasis, Vaginal Yeast Infection, Bacterial Vaginosis, Yeast Infections in Men, Balanitis, Cytomegalovirus, Mycoplasma, Mononucleosis…]

Though sin of every species has a tendency to destroy life, yet none are so mortal as fornication; By the just judgment of God, all these irregular and sinful connections are married to death. Neither prostitutes, whoremongers, nor unclean persons of any description, can live out half their days: The show of their countenance doth witness against them, and they declare their sin as Sodom, they hide it not; woe unto their soul, for they have rewarded evil unto themselves.

The University of Alberta has started a clinical trial to try to fight a syphilis outbreak in Edmonton and across northern Alberta.

An outbreak was declared last year by Alberta Health Services after 12 stillborn births and 1,753 newly diagnosed cases of syphilis, a highly infectious sexually transmitted infection.

"Edmonton, in addition to being the epicentre for COVID, is also the epicentre for syphilis," Dr. Ameeta Singh, a U of A clinical professor who's leading the trial, said Monday in an interview with The Canadian Press.

Case counts, she said, have continued to rise since the syphilis outbreak was declared in July 2019.

Continue Reading.

Researchers at the University of Waterloo have developed a new way to prevent and treat Chlamydia, the most common sexually transmitted bacterial infection in the world.

The new treatment differs from the traditional antibiotic treatment as it is a type of gene therapy that is delivered via nanotechnology and is showing a 65 per cent success rate in preventing chlamydia infection on a single dose.